Suppr超能文献

接受和未接受双膦酸盐治疗的成骨不全症患者的牙齿发育时机。

Timing of dental development in osteogenesis imperfecta patients with and without bisphosphonate treatment.

作者信息

Vuorimies Ilkka, Arponen Heidi, Valta Helena, Tiesalo Outi, Ekholm Marja, Ranta Helena, Evälahti Marjut, Mäkitie Outi, Waltimo-Sirén Janna

机构信息

Folkhälsan Institute of Genetics, Helsinki, Finland; Children's Hospital, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.

Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland.

出版信息

Bone. 2017 Jan;94:29-33. doi: 10.1016/j.bone.2016.10.004. Epub 2016 Oct 7.

Abstract

Bisphosphonates have established their role as medical therapy for pediatric osteogenesis imperfecta (OI) patients. Since bisphosphonates have also been shown to delay tooth development in animal models, we aimed to assess whether the medication has a similar effect on children with OI. In this cross-sectional study, bisphosphonate-treated OI patients of whom dental panoramic tomograph was taken between 3 and 16years of age formed the study group. The patients, 22 in total, had been treated with pamidronate, zoledronic acid or risedronate for at least one year before the radiography. Developmental stage of the permanent teeth, resorption of the deciduous teeth, and number of the erupted permanent teeth were radiographically assessed in the left mandibular quadrant. Dental panoramic tomographs of 50 OI patients, naïve to bisphosphonates, and of 50 healthy individuals of the same age were used as controls. The dental development was statistically significantly accelerated in the OI group naïve to bisphosphonates showing median advancement of dental age by 0.63years from chronological age and median increase in the number of erupted teeth by 0.31 as compared to Finnish norms. Bisphosphonate-treated OI patients displayed, however, age-appropriate dental development. The OI patients not treated with bisphosphonates also showed statistically significantly faster resorption of the deciduous teeth than the treated ones, and displayed an altered interrelationship between the resorption stage of an individual primary tooth and the developmental stage of the succedaneous permanent tooth, unlike the OI patients treated with bisphosphonate. No correlation between either cumulative bisphosphonate dose or between treatment length and any measured component of the dental development was found. To conclude, OI itself was found to lead to advanced dental development. Bisphosphonate treatment had a delaying effect in all the three aspects studied, resulting in a rate of dental development indistinguishable from normal.

摘要

双膦酸盐已确立其在小儿成骨不全(OI)患者医学治疗中的作用。由于双膦酸盐在动物模型中也被证明会延迟牙齿发育,我们旨在评估该药物对OI患儿是否有类似影响。在这项横断面研究中,研究组由3至16岁间进行过牙科全景断层扫描的接受双膦酸盐治疗的OI患者组成。总共22例患者在进行影像学检查前至少已接受帕米膦酸、唑来膦酸或利塞膦酸治疗一年。对左下颌象限恒牙的发育阶段、乳牙的吸收情况以及萌出恒牙的数量进行影像学评估。选取50例未接受过双膦酸盐治疗的OI患者和50例同龄健康个体的牙科全景断层扫描作为对照。未接受双膦酸盐治疗的OI组牙齿发育在统计学上显著加速,与芬兰标准相比,牙齿年龄中位数比实际年龄提前0.63岁,萌出牙齿数量中位数增加0.31颗。然而,接受双膦酸盐治疗的OI患者牙齿发育与年龄相符。未接受双膦酸盐治疗的OI患者乳牙吸收在统计学上也显著快于接受治疗的患者,并且与接受双膦酸盐治疗的OI患者不同,单个乳牙的吸收阶段与继承恒牙的发育阶段之间的相互关系发生了改变。未发现双膦酸盐累积剂量或治疗时长与牙齿发育的任何测量指标之间存在相关性。总之,发现OI本身会导致牙齿发育提前。双膦酸盐治疗在所研究的三个方面均有延迟作用,使牙齿发育速度与正常情况无差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验